Adeyeye receives African Leadership Award
Analysis based on 6 articles · First reported Jul 08, 2026 · Last updated Jul 10, 2026
The recognition highlights NAFDAC's improved regulatory standards, which could boost investor confidence in Nigeria's pharmaceutical sector and facilitate exports of locally manufactured medicines. The reforms may attract further international investment and partnerships, positively impacting the Nigerian pharmaceutical industry.
Prof. Mojisola Adeyeye, Director-General of Nigeria's United States — Food and Drug Administration (NAFDAC), received the Special African Leadership Commendation Award at the 16th African Business Leadership Awards held at the House of Lords, London, on July 3, 2026. The award, conferred by the African Leadership Organisation, recognized her leadership in transforming NAFDAC from an institution with over ₦3.2 billion debt and non-functional laboratories into a globally recognized regulatory agency. Under her tenure, NAFDAC achieved WHO Maturity Level 3, ISO 9001 certification, digitized 90% of processes, reduced pharmaceutical imports by 70%, and attracted partners including the Gates Foundation, UNICEF, and the European Union. Nigeria also became a member of the International Council for Harmonisation and attained pre-applicant status in the Pharmaceutical Inspection and Cooperation Scheme. Adeyeye delivered a keynote address on African university reform. NAFDAC is now working towards WHO Maturity Level 4 and World Listed Authority status.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard